Medicare Enrolled

Dr. Ruby Ali, M.D.

Neurology · Fairfield, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1860 PENNSYLVANIA AVENUE, Fairfield, CA 94533
7076464380
In practice since 2008 (18 years)
NPI: 1093990426 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ali

Dr. Ruby Ali is a neurology specialist in Fairfield, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ali performed 9,042 Medicare services across 527 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ali received a total of $16,815 from 73 pharmaceutical and/or device companies across 843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 10% volume in CA $16,815 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,042
Medicare services
Top 10% in CA for neurology
527
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~502 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
8,355 $5 $11
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
369 $99 $317
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
126 $137 $472
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
90 $73 $219
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
47 $126 $422
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
40 $139 $423
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
15 $85 $115
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,815
Total received (2018-2024)
Avg $2,402/year across 7 years
Top 17% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
843
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,783 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,585
2023
$2,730
2022
$2,371
2021
$2,643
2020
$1,074
2019
$1,586
2018
$1,826

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$1,516
ABBVIE INC.
$1,341
PFIZER INC.
$267
Celgene Corporation
$180
Alexion Pharmaceuticals, Inc.
$134
Biogen, Inc.
$132
SCILEX PHARMACEUTICALS INC.
$105
JAZZ PHARMACEUTICALS INC.
$76
ARGENX US, INC.
$74
GE HEALTHCARE
$74
UCB, Inc.
$73
BANNER LIFE SCIENCES, LLC
$69
Amneal Pharmaceuticals LLC
$69
SK Life Science, Inc.
$49
Novartis Pharmaceuticals Corporation
$46
Merz Pharmaceuticals, LLC
$46
Aucta Pharmaceuticals, Inc.
$44
Kyowa Kirin, Inc.
$44
Lilly USA, LLC
$41
ACADIA Pharmaceuticals Inc
$41
Eisai Inc.
$36
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
Genentech USA, Inc.
$24
Janssen Biotech, Inc.
$23
EMD Serono, Inc.
$23
Genentech, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Top 3 companies account for 68.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,025
LivaNova USA, Inc.
$1,797
AbbVie Inc.
$1,245
UCB, Inc.
$1,026
Biogen, Inc.
$926
GENZYME CORPORATION
$656
Allergan, Inc.
$605
Allergan Inc.
$543
PFIZER INC.
$514
SK Life Science, Inc.
$467
EMD Serono, Inc.
$445
Novartis Pharmaceuticals Corporation
$442
Teva Pharmaceuticals USA, Inc.
$425
ACADIA Pharmaceuticals Inc
$385
Biohaven Pharmaceuticals, Inc.
$382
Celgene Corporation
$354
Lilly USA, LLC
$297
Amneal Pharmaceuticals LLC
$276
Janssen Biotech, Inc.
$266
Amgen Inc.
$231
Biohaven Pharmaceutical Holding Company Ltd.
$227
Supernus Pharmaceuticals, Inc.
$213
Janssen Pharmaceuticals, Inc
$195
Alexion Pharmaceuticals, Inc.
$168
ARGENX US, INC.
$157
Takeda Pharmaceuticals U.S.A., Inc.
$155
Horizon Therapeutics plc
$154
Neurocrine Biosciences, Inc.
$120
Genentech USA, Inc.
$110
JAZZ PHARMACEUTICALS INC.
$107
SCILEX PHARMACEUTICALS INC.
$105
Merz Pharmaceuticals, LLC
$104
GE HEALTHCARE
$93
BANNER LIFE SCIENCES, LLC
$91
MITSUBISHI TANABE PHARMA AMERICA, INC.
$82
US WorldMeds, LLC
$81
Lundbeck LLC
$78
Adamas Pharmaceuticals, Inc.
$72
Integra LifeSciences Corporation
$69
RedHill Biopharma Inc.
$59
CSL Behring
$58
Eisai Inc.
$57
Scilex Pharmaceuticals Inc.
$55
Greenwich Biosciences, Inc.
$54
Merz North America, Inc.
$49
Aucta Pharmaceuticals, Inc.
$44
Kyowa Kirin, Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$43
INTERCEPT PHARMACEUTICALS, INC.
$42
Sunovion Pharmaceuticals Inc.
$40
EISAI INC.
$39
Neurelis, Inc.
$38
NeuroPace, Inc.
$38
Intercept Pharmaceuticals, Inc.
$35
GE Healthcare
$34
ANI Pharmaceuticals, Inc.
$33
Impax Laboratories, Inc.
$33
Acorda Therapeutics, Inc
$31
Promius Pharma LLC
$25
Banner Life Sciences, LLC
$23
Ethicon US, LLC
$23
Braintree Laboratories, Inc.
$23
IMPEL PHARMACEUTICALS INC.
$22
Mallinckrodt LLC
$22
TG THERAPEUTICS, INC.
$21
Grifols USA, LLC
$20
Mitsubishi Tanabe Pharma America, Inc.
$20
Avanir Pharmaceuticals, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Genentech, Inc.
$17
NEUROPACE, INC.
$15
Vertical Pharmaceuticals, LLC
$15
GlaxoSmithKline, LLC.
$15
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · CODMAN CERTAS · CREXONT · DAYBUE · ELYXYB · ELYXYB - CELECOXIB · EMGALITY · ENTYVIO · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hizentra · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MYOBLOC · Mavenclad · Motpoly XR · Movantik · NUCALA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCALIVA · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OSMOLEX ER · OXTELLAR XR · Ocrevus · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REMICADE · REYVOW · RNS System · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · STELARA · SUTAB · TECFIDERA · TROKENDI XR · TYSABRI · Talicia · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XARELTO · XEOMIN · XIFAXAN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Fairfield?
Compare neurologists in the Fairfield area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
39
Per 100K population
8.7
County median income
$99,994
Nearest hospital
NORTHBAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ali is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ali experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Ali performed 8,355 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $16,815 from 73 companies across 843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ali's costs compare to other neurologists in Fairfield?
Dr. Ali's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →